Evaluation of mucilage of Hibiscus rosasinensis Linn as rate controlling matrix for sustained release of diclofenac

Drug Development and Industrial Pharmacy

Volumn 34, Issue 8, 2008, Pages 807-816

  Jani, Girish K ^a,c   Shah, Dhiren P ^b  

^a Shri AK Raval Charitable Trust   (India)

^b CKPithawalla Institute Of Pharmaceutical Science and Research   (India)

^c SSR College of Pharmacy ^*  (India)

Author keywords

Diclofenac sodium; Factorial design; Hibiscus rosasinensis Linn; Hydrophilic polymer; Mucilage; Sustained release

Indexed keywords

CALCIUM PHOSPHATE DIBASIC; DICLOFENAC; EXCIPIENT; HIBISCUS ROSASINENSIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG FORMULATION; FACTORIAL DESIGN; HARDNESS; HIBISCUS; MUCILAGE; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SUSTAINED DRUG RELEASE; TABLET COMPRESSION;

ADHESIVES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HIBISCUS; LETHAL DOSE 50; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; TABLETS;

EID: 49449092611     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040801925768     Document Type: Article

References (46)

1. Adhirajan, N., Ravikumar, T., Shanmugasundram, N., & Babu, M. (2003). In vivo and in vitro evaluation of hair growth potential of Hibiscus rosasinensis Linn. J. Ethnopharmacol., 88, 235-239.
2. Anjaria, J., Parabia, M., & Dwivedi, S. (2002). Ethno vet heritage - Indian ethno veterinary medicine an overview. Ahmedabad, India: Pathik Enterprise.
3. Ayhan, S., Yalem, O., & Askin, I. (2005). Preparation and in-vitro evaluation of sustained release tablet formulations of diclofenac sodium. Farmaco., 60, 171-177.
4. Bamba, M., & Puisieusx, F. (1979). Release mechanism in gel forming sustained release preparations. Int. J. Pharm., 2(5-6), 307-315.
5. Baveja, S. K., Ranga Rao, K. V., & Arora, J. (1988). Examination of natural gums and mucilage as sustaining materials in tablet dosage forms. Indian J. Pharm. Sci., 50(2), 89-92.
6. Beveridge, R. J., Stoddart, J. F., Szarek, W. A., & Jones, J. K. N. (1969). Some structural features of the mucilage from the bark of Ulmus fulva (slippery elm mucilage). Carbohydr. Res., 9(4), 429-439.
7. Bharadia, P. D., Patel, M. M., Patel, G. C., & Patel, G. N. (2004). A preliminary investigation on sesbania gum as a pharmaceutical excipients. Int. J. Pharm. Excipients, 1(4), 99-102.
8. Billa, N., & Yuen, K. H. (2000). Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS PharmaSciTechnol., 1(4), 1-8.
9. Bowen, F. E., & Vadino, W. A. (1984). A simple method for differentiating starches. Drug Dev. Ind. Pharm., 10, 505-511.
10. Chowdary, K. P. R., Mohapatra, P., & Murali Krishna, M. N. (2006). Evaluation of olibanum and its resin as rate controlling matrix for controlled release of diclofenac. Indian J. Pharm. Sci., 68(4), 497-500.
11. Colombo, P., Cante, U., Gazzaja, A., Maggi, L., Sangalli, M. E., & Peppas, N. A. (1990). Drug release modulation by physical restriction of matrix swelling. Int. J. Pharm., 63(1), 43-48.
12. Dale, L. M., & Philip, J. C. (2000). Compressed xanthan and karaya gum matrices: Hydration, erosion and drug release mechanism. Int. J. Pharm., 203, 179-192.
13. Duke, J. A., & Ayensu, E. S. (1985). Medicinal plants of china. Algonac, MI: Reference Publication Inc.
14. Fowler, P. D., Shadforth, M. F., Crook, P. R., & John, V. A. (1983). Plasma and synovial fluid concentration of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur. J. Clin. Pharmacol., 25, 389-394.
15. Gilbert, S. B., & Neil, R. A. (1987). Tablets. In L. Lachman, H. A. Lieberman, & J. L. Kanig (Eds), The theory and practice of industrial pharmacy (pp. 293-344). Bombay, India: Varghese Publishing House.
16. Gohel, M. C., & Patel, K. V. (1997). Formulation optimization of diltiazem-HCl matrix tablets containing modified ispaghula husk using factorial design. Drug Dev. Ind. Pharm., 23(11), 1055-1061.
17. Gohel, M. C., Patel, M. M., & Amin, A. F. (2003). Development of modified release diltiazem HCl tablets using composite index to identify optimal formulation. Drug Dev. Ind. Pharm., 29(5), 565-574.
18. Hardman, J. G., & Limbrid, L. E. (1995). Goodman's and Gilman's, the pharmacological basis of therapeutics. New York: McGraw Hill.
19. Helton, S., Francisco, V. M., Eugenia, P., & Joao, J. S. (2005). Compaction, compression and drug release properties of diclofenac sodium and ibuprofen pellets comprising xanthan gum as a sustained release agent. Int. J. Pharm., 295(1-2), 15-27.
20. Ivan, A. R. (1999). Medicinal plants of the world - chemical constituents, traditional and modern medicinal uses (pp. 155-163). Totawa, NJ: Humana Press.
21. Jerome, M., Pomplia, I., & Mircea, A. M. (2004). Cross-linked high amylase starch derivatives for drug release II. Swelling properties and mechanistic study. Int. J. Pharm., 278(2), 231-238.
22. Kirtikar, K. R., & Basu, B. D. (1999). Indian medicinal plants (p. 335). Dehradun, India: International Book Distributors.
23. Melike, U., & Turan, A. (2004). Evaluation of honey locust (Gleditsia triacanthos Linn). Gum as sustaining material in tablet dosage form. Farmaco., 59(7), 567-573.
24. Morkhade, D. M., Fulzele, S. V., Satturwar, P. M., & Joshi, S. B. (2006). Gum copal and gum damar: Novel matrix forming material for sustained drug delivery. Indian J. Pharm. Sci., 68(1), 53-58.
25. Mudgal, V. N. (1974). Botanical description of Hibiscus rosasinensis (china rose of shoe flower of japakusum). J. Res. Indian Med., 9, 105.
26. Munday, D. L., & Philip, J. C. (2000). Compressed xanthan and karaya gum matrices: Hydration, erosion and drug release mechanisms. Int. J. Pharm., 203(1-2), 179-192.
27. Nurjaya, S., & Wong, T. W. (2005). Effects of microwave on drug release properties of matrices of pectin. Carbohydr. Polym., 62(3), 245-257.
28. Peck, G. E., Johnson, A. D., & Anderson, V. L. (1990). Statistical approach for the development of an oral controlled-release matrix tablets. Pharm. Res., 7, 1092-1097.
29. Pullaiah, T. (2006). Encyclopedia of world medicinal plants (Vol. 3, p. 1085). New Delhi, India: Regency Publication.
30. Sachdewa, A., & Khemani, L. D. (2003). Effect of Hibiscus rosasinensis Linn. Ethanol flower extract on blood glucose and lipid profile in streptozotocin induced diabetes in rats. J. Ethnopharmacol., 89, 61-66.
31. Sachdewa, A., Nigam, R., & Khemani, L. D. (2001). Hypoglycemic effects of Hibiscus rosasinensis Linn leaf extract in glucose and streptozotocin induced hyperglycemic rats. Indian J. Exp. Biol, 39, 284-286.
32. Sanford, B., & Charles, B. (2004). Factorial designs. In S. James (Ed.), Pharmaceutical statistics - practical and clinical application (pp. 265-288). New York: Marcel Dekker Inc.
33. Santiago, P., Claudia, L., Juan, M. L., Gloria, B., Ruben, H. M., & Daniel, A. A. (2002). Design of Peumus boldus tablets by direct compression using a novel dry plant extract. Int. J. Pharm., 233(1-2), 191-198.
34. 2. Pharm. Res., 15(6), 889-895.
35. Shimizu, N., Tomoda, M., Suzuki, I., & Takada, K. (1993). Plant mucilages. XLIII. A representative mucilage with biological activity from the leaves of hibiscus rosa-sinensis. Biol. Pharm. Bull., 16(8), 735-739.
36. Sumathi, S., & Ray, A. R. (2002). Release behavior of drugs from tamarind seed polysaccharide tablets. J. Pharm. Pharmaceut. Sci., 5(1), 12-18.
37. Thomas, D., & Reza, F. (2002). Guar based monolithic matrix systems: Effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics. J. Control. Release, 80(1-3), 45-56.
38. Toti, U. S., & Aminabhavi, T. M. (2004). Modified guar gum matrix tablet for controlled release diltiazem hydrochloride. J. Control. Release, 95(3), 567-577.
39. Ughini, F., Andreazza, I. F., Ganter, J. L. M. S., & Bresolin, T. M. B. (2004). Evaluation of xanthan and highly galactomannan from M. Scabrella as a sustained release matrix. Int. J. Pharm., 271(1-2), 197-205.
40. Vendruscolo, C. W., Andreazza, I. F., Ganter, J. L. M. S., Ferrero, C., & Bresolin, T. M. B. (2005). Xanthan and galactomannan (from M. Scabrella) matrix tablets for oral controlled delivery of theophylline. Int. J. Pharm., 296(1-2), 1-11.
41. Wahi, S. P., Sharma, V. D., Jain, V. K., & Sinha, P. (1985). Studies on suspending property of mucilage of hygrophila spinosa T. Anders and Hibiscus esculents Linn. Indian Drug., 22(9), 500-502.
42. Wataru, K. (2003). Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulation. Int. J. Pharm., 258(1-2), 55-64.
43. National Institute of Science and Communication. (2002). The Wealth of India, first supplement series (raw materials) (Vol. 3, D-I, pp. 386-387). New Delhi, India: CSIR.
44. National Institute of Science and Communication. (2004). The Wealth of India, first supplement series (raw materials) (Vol. 5, H-K, pp. 91-92). New Delhi, India: CSIR.
45. Willis, J. V., Kendall, M. J., & Jack, D. B. (1981). The influence of food on the absorption of diclofenac after single and multiple oral doses. Eur. J. Clin. Pharmacol., 19, 33-37.
46. Yasunori, M., Shigeru, Y., & Kozo, T. (2004). Study on jelly fig extract as a potential hydrophilic matrix controlled drug delivery. Int. J. Pharm., 287(1-2), 39-46.